PAYMENTS, NOTICES AND OTHER COMMUNICATIONS. Any payment, notice or other communication pursuant to this Agreement shall be sufficiently made or given on the date of receipt if sent to such party by telefax or overnight courier, or on the date three days after mailing if sent by certified mail, postage prepaid, addressed to it at its address below or as it shall designate by written notice given to the other party: In the case of UNIVERSITY: Intellectual Property Office Office of the Vice Chancellor of Research University of Illinois at Chicago 0000 Xxxx Xxxx Xxxxxx, 312 AOB (M/C 672) Xxxxxxx, Xxxxxxxx 00000 ATTN: Director, Intellectual Property Office In the case of LICENSEE: Quark Biotech, Inc. c/o QBI Enterprises, Ltd. Weizmann Scientific Park Building 3, 4th Floor P. X. Xxx 000 Xxx Xxxxx, Xxxxxx 00000 ATTN: Xxxxxx Xxxx, President & CEO FAX: 000-000-0-000-0000
Appears in 3 contracts
Samples: Exclusive License Agreement (Quark Pharmaceuticals Inc), Exclusive License Agreement (Quark Pharmaceuticals Inc), Exclusive License Agreement (Quark Biotech Inc)
PAYMENTS, NOTICES AND OTHER COMMUNICATIONS. Any payment, notice or other communication pursuant to this Agreement shall be sufficiently made or given on the date of receipt if sent to such party by telefax or overnight courier, or on the date three days after mailing if sent by certified mail, postage prepaid, addressed to it at its address below or as it shall designate by written notice given to the other party: In the case of UNIVERSITY: Intellectual Property Office Office of the Vice Chancellor of Research University of Illinois at Chicago 0000 X. Xxxx Xxxx XxxxxxStreet, 312 AOB (M/C 672) Xxxxxxx, Xxxxxxxx 00000 ATTN: Director, Intellectual Property Office In the case of LICENSEE: Quark Biotech, Inc. c/o QBI Enterprises, Ltd. Weizmann Scientific Park Building 3, 4th Floor P. X. X.X. Xxx 000 Xxx Xxxxx, Xxxxxx 00000 ATTNAttn: Xxxxxx Xxxx, President & CEO FAX: 000-000-0-000-0000
Appears in 2 contracts
Samples: Exclusive License Agreement (Quark Pharmaceuticals Inc), Exclusive License Agreement (Quark Pharmaceuticals Inc)